Important progress achieved in BioInvent’s immunotherapeutic programmes
LUND, Sweden--(BUSINESS WIRE)--Regulatory News:
BioInvent (STO:BINV)
Third quarter 2016, July - September
LUND, Sweden--(BUSINESS WIRE)--Regulatory News:
BioInvent (STO:BINV)
Third quarter 2016, July - September